Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6176
PUT
Icahn Enterprises
IEP
$5.46B
| $323K | ﹤0.01% |
6,100
+300
| +5% | +$16.3K |
|
6177
PUT
iShares US Oil Equipment & Services ETF
IEZ
$367M
| $323K | ﹤0.01% |
+9,000
| New | +$303K |
|
6178
Live Oak Bancshares
LOB
$1.96B
| $323K | ﹤0.01% |
+13,536
| New | +$327K |
|
6179
CVR Partners
UAN
$1.34B
| $323K | ﹤0.01% |
9,853
+7,108
| +259% | +$236K |
|
6180
CALL
Watsco Inc
WSO
$13.2B
| $323K | ﹤0.01% |
1,900
-2,200
| -54% | -$363K |
|
|
FMSA
6181
CALL
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $323K | ﹤0.01% |
61,700
-46,600
| -43% | -$219K |
|
6182
PUT
AnaptysBio
ANAB
$1.63B
| $322K | ﹤0.01% |
+3,200
| New | +$236K |
|
6183
CALL
Dolby
DLB
$5.76B
| $322K | ﹤0.01% |
5,200
-6,300
| -55% | -$381K |
|
6184
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
| $322K | ﹤0.01% |
10,688
+2,025
| +23% | +$59.6K |
|
6185
Tractor Supply
TSCO
$17.8B
| $322K | ﹤0.01% |
21,530
-6,828,825
| -100% | -$87.7M |
|
6186
CALL
ProShares UltraShort Yen
YCS
$29.2M
| $322K | ﹤0.01% |
17,200
-56,800
| -77% | -$1.06M |
|
6187
PUT
Emergent Biosolutions
EBS
$279M
| $321K | ﹤0.01% |
+6,900
| New | +$290K |
|
6188
CALL
Lincoln Electric
LECO
$15.3B
| $321K | ﹤0.01% |
3,500
-1,200
| -26% | -$110K |
|
6189
PUT
News Corp Class A
NWSA
$15.9B
| $321K | ﹤0.01% |
19,800
-3,100
| -14% | -$46.4K |
|
6190
CALL
CDW
CDW
$17.4B
| $320K | ﹤0.01% |
4,600
+100
| +2% | +$6.88K |
|
6191
ProShares Ultra Energy
DIG
$76.9M
| $320K | ﹤0.01% |
6,455
-17,321
| -73% | -$774K |
|
6192
Lineage Cell Therapeutics
LCTX
$282M
| $320K | ﹤0.01% |
170,094
+95,014
| +127% | +$207K |
|
|
TGI
6193
DELISTED
Triumph Group
TGI
| $320K | ﹤0.01% |
+11,757
| New | +$352K |
|
|
AKAO
6194
CALL
DELISTED
Achaogen Inc
AKAO
| $320K | ﹤0.01% |
+29,800
| New | +$374K |
|
|
ANW
6195
DELISTED
Aegean Marine Petroleum Network
ANW
| $320K | ﹤0.01% |
+74,433
| New | +$314K |
|
|
MSCC
6196
CALL
DELISTED
Microsemi Corp
MSCC
| $320K | ﹤0.01% |
+6,200
| New | +$326K |
|
6197
Employers Holdings
EIG
$900M
| $319K | ﹤0.01% |
+7,192
| New | +$339K |
|
6198
PUT
Flowers Foods
FLO
$1.54B
| $319K | ﹤0.01% |
16,500
-3,100
| -16% | -$59.5K |
|
6199
TTEC Holdings
TTEC
$127M
| $318K | ﹤0.01% |
7,910
+739
| +10% | +$30.4K |
|
6200
PUT
Xcel Energy
XEL
$47.9B
| $318K | ﹤0.01% |
6,600
+1,600
| +32% | +$79.4K |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.